Evidence map›Paper›PMID 42221819›Full record

ArticleiScience2026

Equivalent low altitude building improves physiological adaptation at high altitude.

Luobu Gesang, Yangzong Suona, Zhuoga Danzeng, Quzhen Gesang, Bai Ci, Dan Ren, Qiangba Dingzeng, Binyun Liu, Qinqin Ma, Ju Huang and 2 more

Abstract read
In one paragraph

Article in iScience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Luobu GesangHigh Altitude Medical Research Institute of Xizang Autonomous Region, Lhasa 850000, China.
Yangzong SuonaHigh Altitude Medical Research Institute of Xizang Autonomous Region, Lhasa 850000, China.
Zhuoga DanzengHigh Altitude Medical Research Institute of Xizang Autonomous Region, Lhasa 850000, China.
Quzhen GesangHigh Altitude Medical Research Institute of Xizang Autonomous Region, Lhasa 850000, China.
Bai CiHigh Altitude Medical Research Institute of Xizang Autonomous Region, Lhasa 850000, China.
Dan RenXizang Autonomous Region People's Hospital, Lhasa 850000, China.
Qiangba DingzengHigh Altitude Medical Research Institute of Xizang Autonomous Region, Lhasa 850000, China.
Binyun LiuHigh Altitude Medical Research Institute of Xizang Autonomous Region, Lhasa 850000, China.
Qinqin MaHigh Altitude Medical Research Institute of Xizang Autonomous Region, Lhasa 850000, China.
Ju HuangHigh Altitude Medical Research Institute of Xizang Autonomous Region, Lhasa 850000, China.
Quzong ZhaxiHigh Altitude Medical Research Institute of Xizang Autonomous Region, Lhasa 850000, China.
Zhuoga BaimaHigh Altitude Medical Research Institute of Xizang Autonomous Region, Lhasa 850000, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic high-altitude exposure contributes to hypoxia-related morbidity. We conducted a randomized crossover trial evaluating overnight exposure to an equivalent low altitude building (ELAB) for 12 weeks in acclimatized adults residing in Lhasa. ELAB significantly improved nocturnal oxygen saturation, reduced hypoxic burden, attenuated hemoglobin increases, and lowered selected blood pressure parameters, while cardiopulmonary exercise capacity remained stable. No serious adverse events occurred. These findings support a medical-engineering strategy to reduce physiological stress associated with chronic high-altitude exposure and provide controlled physiological evidence for a non-pharmacological intervention.

Indexed as

construction engineeringenvironmental medicinemedicine

Identifiers

PMID42221819
PMCPMC13217843

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.